SCHEMBL286760

SCHEMBL286760

NC(=O)OCc1ccccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.54
CASP3 P42574 3/20 0.53
SENP8 Q96LD8 3/20 0.53
SENP7 Q9BQF6 3/20 0.53
SENP6 Q9GZR1 3/20 0.53
MMP1 P03956 1/20 0.53
MMP2 P08253 1/20 0.53
MMP9 P14780 1/20 0.53
MMP12 P39900 1/20 0.53
RAB9A P51151 4/20 0.50
MAPT P10636 2/20 0.50
NR4A2 P43354 2/20 0.50
POLB P06746 2/20 0.49
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
PKM P14618 2/20 0.48
NPC1 O15118 3/20 0.48
ALDH1A1 P00352 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3192708 0.86 IDO1 (0.50) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL29501710 0.86 SMN1; SMN2 (0.48) IDO1MAOBPKMALDH1A1LMNA
SCHEMBL722953 0.85 IDO1 (0.59) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL9815841 0.84 L3MBTL1 (0.57) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL984297 0.84 L3MBTL1 (0.57) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL11581518 0.82 L3MBTL1 (0.55) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL4374949 0.82 L3MBTL1 (0.59) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL140814 0.82 ALDH1A1 (0.57) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL28803183 0.82 FFAR4 (0.43) IDO1L3MBTL1CASP3SENP8SENP7
SCHEMBL1821613 0.81 TAAR1 (0.50) IDO1RAB9APOLBPKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 684 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026089784-A2 COMPOUNDS AND COMPOSITIONS FOR CONJUGATION TO BIOLIGANDS FOR IMAGING AND RADIOPHARMACEUTICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2026-04-30 WO disclosed
WO-2025151874-A1 INDOLE ALKALOID ANTIPLASMODIAL AGENTS AND PREPARATION THEREOF UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2025-07-17 WO disclosed
WO-2024147060-A1 NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY CELON PHARMA S.A. (PL) 2024-07-11 WO disclosed
WO-2024133853-A1 BIS-ESTER AND AMIDE CATIONIC LIPIDS SANOFI (FR) 2024-06-27 WO disclosed
WO-2024112854-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed
EP-4370132-A2 MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS Alnylam Pharmaceuticals, Inc. (US) 2024-05-22 EP disclosed
EP-4370503-A1 ESTERS OF A RETINOID AND BAKUCHIOL AND PREPARATIONS THEREOF Conagen Inc. (US) 2024-05-22 EP disclosed
WO-2024097746-A1 ALKENE CYCLOPROPANATION WITH NICKEL CATALYST ENHANCER AND IMPROVED REARRANGEMENT REACTION CONAGEN INC. (US) 2024-05-10 WO disclosed
WO-2024097228-A1 COMPOUNDS TARGETING CDK11 AND METHODS OF USING THE SAME MELIORA THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed
WO-2024086826-A2 POLYPEPTIDYL LINKERS Quantum-Si Incorporated (US) 2024-04-25 WO disclosed
WO-2002053724-A2 ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-07-11 WO disclosed
EP-0970066-A1 AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT G.D. SEARLE & CO. (US) 2000-01-12 EP disclosed
US-5831001-A ADMINISTERING OLIGOPEPTIDE WITH ARGININE UNITS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1998-11-03 US disclosed
US-5789531-A Peptide-based inhibitors of HIV replication ALLEX BIOPHARMACEUTICALS, INC. (CA) 1998-08-04 US disclosed
WO-1998029401-A1 AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT G.D. SEARLE & CO. (US) 1998-07-09 WO disclosed
EP-0804410-A1 METHOD OF PREPARING RETROVIRAL PROTEASE INHIBITOR INTERMEDIATES G.D. SEARLE & CO. (US) 1997-11-05 EP disclosed
US-5646120-A OLIGO- AND POLYARGININE AND DERIVATIVES ALLELIX BIOPHARMACEUTICALS, INC. (CA) 1997-07-08 US disclosed
EP-0730570-A1 METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-09-11 EP disclosed
WO-1996022275-A1 METHOD OF PREPARING RETROVIRAL PROTEASE INHIBITOR INTERMEDIATES G.D. SEARLE & CO. (US) 1996-07-25 WO disclosed
CN-1088384-A Contain the agricultural fungicide and the application thereof of N-(benzyloxy of replacement) imine derivative NIHON NOHYAKU CO LTD (JP) 1994-06-29 CN disclosed